Takuya Ayabe

Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells.

[Anaphylaxia induced by etoposide--a case report].

Pituitary apoplexy as a consequence of lymphocytic adenohypophysitis in a pregnant woman: a case report.

[An outline of GnRH analogue].

[Clinical application of GnRH antagonist to uterine fibroid].

[Secondary amenorrhea].

[Concurrent chemoradiation therapy for advanced cervical cancer].

Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride.

Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.

[Acute myelogenous leukemia developed at the 26th week of gestation].

Spinal cord infarction in diabetic pregnancy: a case report.

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer.

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.

Detection of HPV RNA molecules in stratified mucin-producing intraepithelial lesion (SMILE) with concurrent cervical intraepithelial lesion: a case report.

On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis UCHL5 inhibition in ovarian cancer.

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.

Rikkunshito attenuates induction of epithelial-mesenchymal switch via activation of Sirtuin1 in ovarian cancer cells.

Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study.

Liver disease in pregnancy.

Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.